|
|
|
Volumn 13, Issue , 1997, Pages 1-47
|
|
Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
BRONCHODILATING AGENT;
CORTICOSTEROID;
MONOCLONAL ANTIBODY;
RIBAVIRIN;
ANIMAL;
CONGENITAL HEART MALFORMATION;
COST BENEFIT ANALYSIS;
DISEASE MODEL;
ECONOMICS;
HUMAN;
IMMUNE DEFICIENCY;
INFANT;
LUNG DYSPLASIA;
METHODOLOGY;
NEWBORN;
PASSIVE IMMUNIZATION;
PATHOLOGY;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
REVIEW;
VACCINATION;
VIRAL BRONCHIOLITIS;
VIRUS INFECTION;
VIRUS PNEUMONIA;
ADRENAL CORTEX HORMONES;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
BRONCHIOLITIS, VIRAL;
BRONCHODILATOR AGENTS;
BRONCHOPULMONARY DYSPLASIA;
COST-BENEFIT ANALYSIS;
DISEASE MODELS, ANIMAL;
HEART DEFECTS, CONGENITAL;
HUMANS;
IMMUNIZATION, PASSIVE;
IMMUNOCOMPROMISED HOST;
INFANT;
INFANT, NEWBORN;
PNEUMONIA, VIRAL;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
RESPIRATORY SYNCYTIAL VIRUS, HUMAN;
RIBAVIRIN;
VACCINATION;
|
|
EID: 0031296628
PISSN: 08849404
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (14)
|
|
References (147)
|
